SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:0041 1337
 

Sökning: L773:0041 1337 > (2018) > Atrial Fibrillation...

Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients

Wange, Niklas (författare)
Anan, Intissar (författare)
Ericzon, Bo-Göran (författare)
visa fler...
Pennlert, Johanna (författare)
Pilebro, Björn (författare)
Suhr, Ole B. (författare)
Wixner, Jonas (författare)
visa färre...
 (utgivare)
 (utgivare)
LIPPINCOTT WILLIAMS & WILKINS 2018
2018
Engelska.
Ingår i: Transplantation. - 0041-1337. ; 102:2, e59-e66
  • swepub:Mat__t
Abstract Ämnesord
Stäng  
  • Background. Central nervous system (CNS) complications are increasingly noted in liver transplanted (LTx) hereditary transthyretin amyloid (ATTRm) amyloidosis patients; this suggests that the increased survival allows for intracranial ATTRm formation from brain synthesized mutant TTR. However, atrial fibrillation (AF), a recognised risk factor for ischemic CNS complications, is also observed after LTx. The aim of the study was to investigate the occurrence of CNS complications and AF in LTx ATTRm amyloidosis patients. Methods. The medical records of all LTx ATTRm amyloidosis patients in the county of Vasterbotten, Sweden, were investigated for information on CNS complications, AF, anticoagulation (AC) therapy, hypertension, cardiac ischemic disease, hypertrophy, and neurological status. Results. Sixty-three patients that had survived for 3 years or longer after LTx were included in the analysis. Twenty-five patients had developed 1 or more CNS complications at a median of 21 years after onset of disease. AF was noted in 21 patients (median time to diagnosis 24 years). Cerebrovascular events (CVE) developed in 17 (median time to event 21 years). CVEs occurred significantly more often in patients with AF (P < 0.002). AC therapy significantly reduced CVEs, including bleeding in patients with AF (P = 0.04). Multivariate analysis identified AF as the only remaining regressor with a significant impact on CVE (hazard ratio, 3.8; 95% confidence interval 1.1-9.5; P = 0.029). Conclusions. AF is an important risk factor for CVE in LTx ATTRm amyloidosis patients, and AC therapy should be considered. However, the increased bleeding risk with AC therapy in patients with intracranial amyloidosis should be acknowledged.

Ämnesord

Medical and Health Sciences  (hsv)
Clinical Medicine  (hsv)
Cardiac and Cardiovascular Systems  (hsv)
Medicin och hälsovetenskap  (hsv)
Klinisk medicin  (hsv)
Kardiologi  (hsv)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy